The EYEGUARD-A study

A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan-Uveitis

This study is currently recruiting participants.

Purpose: The primary objective of this study is to demonstrate the superiority of gevokizumab (at least one of the two doses) compared to placebo in the treatment of subjects with active non-infectious intermediate, posterior, or pan- uveitis. In addition, the safety of gevokizumab will be assessed.

Eligibility:

Contact Information

C. Michael Samson, MD, Uveitis Specialist

Alex Yang, Clinical Research Coordinator at (212) 979-4024
or ayang@nyee.edu

 

Home > Current Research > Clinical Trials in Ophthalmology >A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan-Uveitis